Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Hair changes are common in AIDS patients and can add to their financial and emotional stress.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Stopping minoxidil caused significant hair loss, but regrowth occurred after resuming use.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The laser comb did not improve hair regrowth in mice with alopecia areata.

Treatment with benzylpenicillin and prednisolone cured the patient's syphilis and hair loss.

Leflunomide is more likely to help treat alopecia areata than cause it.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

HIV can cause unusual and severe skin problems that are hard to treat.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Itraconazole was effective in treating unusual M. canis infections in only one of two HIV-infected men.

Regulatory T cells are essential for normal and improved wound healing in mice.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.